Advanced Search

Home > Journals > Minerva Endocrinologica > Past Issues > Articles online first > Minerva Endocrinologica 2016 May 19

ISSUES AND ARTICLES   MOST READ   eTOC

CURRENT ISSUEMINERVA ENDOCRINOLOGICA

A Journal on Endocrine System Diseases

Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,118

Frequency: Quarterly

ISSN 0391-1977

Online ISSN 1827-1634

 

Minerva Endocrinologica 2016 May 19

Diabetes mellitus and heart failure: a review of the use of antidiabetic medications in patients with heart failure

Marylene M. SAMIA EL HAYEK, Maya F. BEYDOUN, Sami AZAR

Department of Internal Medicine, Division of Endocrinology and Metabolism, American University of Beirut-Medical Center, NY, USA

Diabetes mellitus increases the mortality secondary to heart failure independent of hypertension and coronary artery disease. Several hypoglycemic agents are used to achieve glycemic control, of which several classes however still raise controversies in terms of safety in patients with concomitant heart failure: Metformin does not carry an increased risk of exacerbation in patients with stable heart failure, yet should be avoided in patients with unstable disease or chronic kidney disease. Sulfonylureas are neither associated with an increased mortality, nor do they seem to have deleterious effects on heart failure. Thiazolidinediones are relatively contraindicated in patients with NYHA (New York Heart Association) class III or IV disease secondary to concerns of fluid retention and heart failure exacerbation. Glucagon like peptide 1 agonists have shown trends towards improvement of heart failure parameters. Dipeptidylpeptidase 4 inhibitors show an overall neutral outcome, although saxagliptin can possibly be associated with an increased risk of hospitalization for heart failure. The use of sodium-glucose co-transporter 2 inhibitors is associated with beneficial cardiovascular outcomes, and further studies are underway.

language: English


FULL TEXT  REPRINTS

top of page